Publishing research using ab102842? Please let us know so that we can cite the reference in this datasheet.

ab102842 has been referenced in 2 publications.

  • Tanaka T  et al. The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer. PLoS One 12:e0177019 (2017). WB ; Human . PubMed: 28472136
  • Kannan K  et al. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma. PLoS Genet 10:e1004216 (2014). WB ; Human . PubMed: 24675677

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up